Results 111 to 120 of about 41,379 (243)

Community pharmacists' practices and perspectives on deprescribing high‐risk psychotropic medicines: National survey findings

British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1911-1921, June 2026.
Aim To explore the practices, confidence and perspectives of community pharmacists in deprescribing high‐risk psychotropic medicines, including opioid analgesics, benzodiazepine, gabapentinoids and medicinal cannabis. Methods An anonymous, cross‐sectional national online survey was conducted between January and April 2025 among Australian community ...
Monica Jung, Louisa Picco, Aili V. Langford, Rose Laing, Jana Dostal, Suzanne Nielsen   +5 more
wiley   +1 more source

Sentience in cephalopod molluscs: an updated assessment

Biological Reviews, Volume 101, Issue 3, Page 1311-1333, June 2026.
ABSTRACT This article evaluates the evidence for sentience – the capacity to have feelings – in cephalopod molluscs: octopus, cuttlefish, squid, and nautilus. Our framework includes eight criteria, covering both whether the animal's nervous system could support sentience and whether their behaviour indicates sentience.
Alexandra K. Schnell, Heather Browning, Andrew Crump, Charlotte C. Burn, Jonathan Birch   +4 more
wiley   +1 more source

Modeling Supports Combinatorial Effects Between Pharmacological and Non‐Pharmacological Interventions to Prevent Opioid‐Induced Cardiac Arrest

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1466-1475, June 2026.
Few studies have quantified the effects of non‐pharmacological interventions (e.g., rescue breathing) in the setting of community opioid overdose. We extended a previously validated model for opioid antagonists by incorporating the mechanism of rescue breathing, and quantified combinatorial effects between rescue breathing and various formulations of ...
Bradlee Thrasher, John Mann, Anik Chaturbedi, Shilpa Chakravartula, Hamed Meshkin, Affan Affan, Alexander Galluppi, Ji Young Kim, Nigar Karimli, Yue Han, Zachary Dezman, Jeffry Florian, Zhihua Li   +12 more
wiley   +1 more source

Adult naloxone administration protocol

, 2018
A tertiary care facility in central Illinois noted an increase in inpatient opioid-related adverse events, including acute opioid withdrawal syndrome due to a higher than a necessary dose of naloxone.
Adhikari, Samuel S
core  

Clinical and demographic characteristics of adolescents, emerging adults, and young adults presenting to an emergency department following a suicide attempt

JCPP Advances, Volume 6, Issue 2, June 2026.
Abstract Introduction Suicide is a significant public health concern and the second leading cause of death in adolescents and young adults. This study sought to better understand differences in demographic and clinical characteristics of young people who attempted suicide during three phases of this developmental period: late adolescence (14–17 years),
Nicholas M. Brdar, Natasha K. Matta, Chloe A. Miner, Mubashshir R. Bhuiyan, Irmgard G. Pallas, Anna L. Bickersteth, Hailey G. Prokop, Lindsay A. Bornheimer   +7 more
wiley   +1 more source

Layperson Naloxone Education

, 2017
The Centers for Disease Control and Prevention (CDC) announced that the opioid overdose crisis is now a nationwide epidemic, with over 60% of overdoses being unintentional.
Noyes, Tiffany
core  

Administering naloxone during COVID-19. Spanish

, 2020
Title from PDF caption (viewed on August 31, 2020)."OHA 2716 SPANISH (08/13/2020)"--Running footer.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Insurance Coverage and Provision of Opioid Disorder Treatment: Evidence From Medicare

Journal of Policy Analysis and Management, Volume 45, Issue 3, Summer 2026.
ABSTRACT Older adult opioid overdose deaths have increased over the past two decades in the United States. Methadone, one of three medications approved for opioid use disorder (OUD) treatment, was not covered by Medicare—the primary insurer of Americans 65 years and older—for OUD until 2020.
Denis Agniel, Jonathan Cantor, Johanna Catherine Maclean, Erin A. Taylor, Kosali Simon   +4 more
wiley   +1 more source

Naloxone Nasal Spray Co-Prescription for the Prevention of Opioid Overdose Complications

, 2023
Background: Opioid overdose is becoming a global epidemic. According to Centers for Disease Control and Prevention (CDC), 67,367 drug overdose deaths occurred in the United States (US) in 2018.
NC DOCKS at East Carolina University, Raju, Princy   +1 more
core  

Naloxone prescription fills and use by patients treated for opioid use disorder by telehealth

Drug and Alcohol Dependence Reports
Background: It is unknown how many people in treatment for opioid use disorder (OUD) have naloxone, use naloxone, and what their perceptions and barriers to obtaining it are.
Scott G. Weiner, Emily N. Miller, Barbara Burke, Brian Clear   +3 more
doaj   +1 more source